Literature DB >> 25642979

Tumorspheres Derived from HCC Cells are Enriched with Cancer Stem Cell-like Cells and Present High Chemoresistance Dependent on the Akt Pathway.

Xiao-Li Zhang, Qian Jia, Lin Lv, Tao Deng, Jian Gao1.   

Abstract

Recent evidence suggests that a small subset of cells within tumors have 'stem cell-like' characteristics. However, direct proof of the population of liver CSCs remains elusive. Further research is needed to identify cells with stem cell properties in established HCC cell lines. Our previous investigation found that tumor spheres are essentially enriched in CSCs. We hypothesized that chemoresistance in hepatocellular carcinoma (HCC) is due to enrichment of cancer stem cells via the PI3K/Akt pathway. We found that tumor spheres cells formed from HCC cells contained a high percentage of CD90(+) cells, and these cells were more tumorigenic and resistant to doxorubicin (DOX), showing a higher proliferation rate and lower apoptosis rate compared to cells in monolayer culture. Treatment with DOX and PI3K/Akt inhibitor increased apoptosis and reduced viability among cells in the tumorspheres. The expression of p-Akt1 was upregulated in tumorsphere-forming cells treated with DOX but downregulated upon further treatment with the PI3K/Akt inhibitor. Our results demonstrate that HCC cells in tumorspheres with cancer stem cell properties achieve chemoresistance via the PI3K/Akt1 pathway.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25642979     DOI: 10.2174/1871520615666150202111721

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  14 in total

1.  A literature mining-based approach for identification of cellular pathways associated with chemoresistance in cancer.

Authors:  Jung Hun Oh; Joseph O Deasy
Journal:  Brief Bioinform       Date:  2015-07-27       Impact factor: 11.622

2.  [Matrine suppresses stemness of hepatocellular carcinoma cells by regulating β-catenin signaling pathway].

Authors:  Meiqin Dai; Zhuo Cai; Nana Chen; Jinzhou Li; Jiayong Wen; Lizhuan Tan; Dan Guo
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-10-30

3.  Dysregulated lipid metabolism in hepatocellular carcinoma cancer stem cells.

Authors:  Alicia Bort; Belén G Sánchez; Irene de Miguel; Pedro A Mateos-Gómez; Inés Diaz-Laviada
Journal:  Mol Biol Rep       Date:  2020-03-03       Impact factor: 2.316

4.  Combination of 5-fluorouracil and 2-morphilino-8-phenyl-4H-chromen-4-one may inhibit liver cancer stem cell activity.

Authors:  Yu-Chong Peng; Shi-Dong Lu; Jian-Hong Zhong; Zhi-Bo Xie; Xue-Mei You; Ning-Fu Peng; Le-Qun Li
Journal:  Tumour Biol       Date:  2016-02-17

5.  The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells.

Authors:  Wang Yin; Dongxi Xiang; Tao Wang; Yumei Zhang; Cuong V Pham; Shufeng Zhou; Guoqin Jiang; Yingchun Hou; Yimin Zhu; Yinglu Han; Liang Qiao; Phuong H-L Tran; Wei Duan
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

6.  Thioridazine has potent antitumor effects on lung cancer stem-like cells.

Authors:  Jiani Shen; Buyun Ma; Xinmin Zhang; Xiaozhu Sun; Jiancui Han; Yigang Wang; Liang Chu; Haineng Xu; Yu Yang
Journal:  Oncol Lett       Date:  2017-01-25       Impact factor: 2.967

7.  Modeling of Hepatocytes Proliferation Isolated from Proximal and Distal Zones from Human Hepatocellular Carcinoma Lesion.

Authors:  Mauro Montalbano; Giuseppe Curcurù; Ali Shirafkan; Renza Vento; Cristiana Rastellini; Luca Cicalese
Journal:  PLoS One       Date:  2016-04-13       Impact factor: 3.240

8.  Cisplatin treatment increases stemness through upregulation of hypoxia-inducible factors by interleukin-6 in non-small cell lung cancer.

Authors:  Fuquan Zhang; Shanzhou Duan; Ying Tsai; Peter C Keng; Yongbing Chen; Soo Ok Lee; Yuhchyau Chen
Journal:  Cancer Sci       Date:  2016-05-03       Impact factor: 6.716

9.  Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma in Vitro and in Vivo.

Authors:  Xueqing Kang; Feng Wang; Xiuwan Lan; Xiaolong Li; Shunxin Zheng; Zhilue Lv; Yuan Zhuang; Yongxiang Zhao; Sufang Zhou
Journal:  Int J Med Sci       Date:  2018-01-01       Impact factor: 3.738

10.  MiR-155 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells through the activation of PI3K/SGK3/β-catenin signaling pathways.

Authors:  Xin Kong; Fengchao Liu; Jian Gao
Journal:  Oncotarget       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.